The 2016 National Research Infrastructure Roadmap (2016 Roadmap) outlines national research infrastructure required over the coming decade so that Australia’s world class research system continued to improve productivity, create jobs, lift economic growth and support a healthy environment.…
Peter Mac’s Professor Mark Dawson has been selected as a Howard Hughes Medical Institute (HHMI) International Research Scholar. The scholarship recognises Prof Dawson as a leading early-career scientist working outside of the G7 group of countries. Prof Dawson…
Monash University and Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, have announced today they have entered into an exclusive agreement. Under the agreement, Corvus has licensed global rights to an undisclosed novel immuno-oncology program, which includes…
An international research team has revealed for the first time that testosterone protects males against developing asthma, helping to explain why females are two times more likely to develop asthma than males after puberty. The study showed that…
Recognition of excellence in Victorian Advanced Manufacturing 10 May 2017, Melbourne: Australian pharmaceutical manufacturing and drug development company IDT Australia Limited (ASX: IDT) has received a Victorian Manufacturing Hall of Fame award in the High Growth Sector of…
Interested parties encouraged to start preparing their applications to share in the $8.2 million of available funding. MTPConnect – the Industry Growth Centre for medical technology, biotechnology and pharmaceutical (MTP) sector – has announced that the second round…
Leading Australian research university, Royal Melbourne Institute of Technology and MGC Pharmaceuticals have signed a Binding Memorandum of Understanding to collaborate on a full suite of medicinal cannabis research initiatives, initially centred on genetics and cultivation. Under the…
An industry-led consortium is set to begin projects that will link industry partners with regenerative medicine academic research and boost the growth of this emerging sector. The consortium, called the Regenerative Medicine Industry Interface, will accelerate commercialisation and…
We are pleased to announce that Professor Elizabeth Hartland has accepted a position as the new Director and CEO of Hudson Institute of Medical Research. Professor Hartland obtained her BSc (Hons) majoring in Microbiology and Biochemistry and subsequently…
An outstanding industry leader with exceptional national and global experience in successfully propelling important biomedical discoveries out of the lab and into the market has been appointed inaugural CEO of BioCurate Pty Ltd. This AUD $80 million venture…
Executive summary Innovation is critical in developing new avenues for economic growth and prosperity for Australia. Innovation can take many different forms and is consequently used and produced by many different businesses. In 2013-14, the manufacturing sector accounted…
The BioMelbourne Network Connecting Women Lunch is now fully booked with over 400 women set to attend on Friday 2nd June. We’re also delighted that we have received a record number of nominations for the BioMelbourne Network Women in Leadership…